1. Home
  2. GOSS vs FUND Comparison

GOSS vs FUND Comparison

Compare GOSS & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • FUND
  • Stock Information
  • Founded
  • GOSS 2015
  • FUND 1988
  • Country
  • GOSS United States
  • FUND Canada
  • Employees
  • GOSS N/A
  • FUND N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • FUND Investment Managers
  • Sector
  • GOSS Health Care
  • FUND Finance
  • Exchange
  • GOSS Nasdaq
  • FUND Nasdaq
  • Market Cap
  • GOSS 203.3M
  • FUND 228.2M
  • IPO Year
  • GOSS 2019
  • FUND N/A
  • Fundamental
  • Price
  • GOSS $1.12
  • FUND $7.14
  • Analyst Decision
  • GOSS Strong Buy
  • FUND
  • Analyst Count
  • GOSS 4
  • FUND 0
  • Target Price
  • GOSS $7.50
  • FUND N/A
  • AVG Volume (30 Days)
  • GOSS 1.6M
  • FUND 32.5K
  • Earning Date
  • GOSS 05-13-2025
  • FUND 01-01-0001
  • Dividend Yield
  • GOSS N/A
  • FUND 6.64%
  • EPS Growth
  • GOSS N/A
  • FUND N/A
  • EPS
  • GOSS N/A
  • FUND 0.93
  • Revenue
  • GOSS $114,701,000.00
  • FUND N/A
  • Revenue This Year
  • GOSS N/A
  • FUND N/A
  • Revenue Next Year
  • GOSS $172.31
  • FUND N/A
  • P/E Ratio
  • GOSS N/A
  • FUND $8.33
  • Revenue Growth
  • GOSS N/A
  • FUND N/A
  • 52 Week Low
  • GOSS $0.50
  • FUND $6.75
  • 52 Week High
  • GOSS $1.55
  • FUND $8.47
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 56.55
  • FUND 51.76
  • Support Level
  • GOSS $1.06
  • FUND $7.09
  • Resistance Level
  • GOSS $1.26
  • FUND $7.21
  • Average True Range (ATR)
  • GOSS 0.11
  • FUND 0.10
  • MACD
  • GOSS 0.04
  • FUND 0.03
  • Stochastic Oscillator
  • GOSS 70.09
  • FUND 80.95

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

Share on Social Networks: